Mastery: Preclinical to Phase IV, Pharmacokinetics,
Pharmacodynamics, Efficacy, Safety, Side Effects,
Idiosyncratic Reactions, DEA Controlled
Substances, Legend Drugs, Prescription Writing,
Phase I-II-III-IV Trials, Proof of Concept, Labeling,
Post-Marketing Surveillance, Adverse Events,
Allergies, High-Yield Clinical Essentials for Exam
Questions Provided with A+ Graded Rationales
Latest Updated 2026
What are the phases of drug development?
1. Preclinical Testing
- in vitro
- animal testing
2. Clinical Testing
- Phase I
- Phase II
- Phase III
3. Marketing
- Phase IV (post marketing surveillance)
Phase I of drug development
HEALTHY human volunteers
- designed to determine drug's pharmacokinetics (dosing) and pharmacodynamics (effect)
**just trying to figure out dosage, what the drug does, how the body reacts etc.
What is the health status of the subjects in Phase I of drug development?
HEALTHY
1|Page
, What phase of drug development is focused on determining pharmacokinetics and
pharmacodynamics in a small population of healthy human volunteers?
Phase I
Phase II of drug development
Small population WITH THE DISEASE is tested
Goal:
- trying to determine proof of concept, aka is the drug working as hypothesized
*** Preliminary assessment of efficacy
What phase of drug development is focused on determining preliminary assessment of efficacy
and hypothesis testing on small populations with the disease for which the medication is
indicated?
Phase II
- proof of concept
Labeling
How the drug is to be used
- abbreviated new drug application
***approved at phase III of drug development
Phase III of drug development
Controlled and uncontrolled trials to gather info about efficacy, safety, and
benefit/relationship
- comparing PTs and affects, placebos etc.
***labeling is approved at this point
What phase of drug development is focused on comparing drug to placebo or standard therapy
to determine efficacy, safety, and benefit/risk relationships?
Phase III
At what point is labeling approved in drug phase development?
Phase III
Phase IV of drug development
2|Page